Page 294 - Syndipharma

Kharazmi Pharmaceutical Co.

Type Product Dosage Form Strength Indication Status

Azithromycin Tablet 250,500 mg Macrolide In market

Clarithromycin Tablet 500 mg Macrolide In market IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Erythromycin Tablet 400 mg Macrolide In market

Gemifloxacin Tablet 320 mg Fluoroquinolone In market

Levofloxacin Tablet 500 mg Fluoroquinolone In market
Antibacterial
Drugs
Ciprofloxacin Tablet 500 mg Fluoroquinolone In market

Co-trimoxazole Tablet 400/80 mg TMP-Sulfamethoxazole In market

Ofloxacin Tablet 200mg Fluoroquinolone In market

Metronidazol Tablet 250 mg Antibiotic In market

Isoniazid Tablet 100.300 mg Anti-tubercular In market

Metformin HCl Tablet 500 mg Biguanide In market
Antidiabetic
Drugs
Sitaglyptin Tablet 25,50 mg Dipeptidyl peptidase - IV In market
inhibitor

Antifungals Griseofulvin Tablet 125,500 mg Antifungal In market

Cetirizine Tablet 10 mg Antihistamine In market

Cetirizine Syrup 5mg/5ml Antihistamine In market

Diphenhydramine Oral Solution 12.5mg/5ml Antihistamine In market
Antihistamines
Diphenhydramine/ Am- Syrup (12.5/125) mg/5 Antihistamine-Expectorant In market
monium Chloride ml

Ketotifen Syrup 1 mg/ 5 ml Antihistamine In market

Hydroxyzine Hydrochlo- Syrup 10 mg/5ml Antihistamine In market
ride 293